[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group (L-carnitine + standard care): 50 patients with COVID-19 diagnosis will be included in the study according to the inclusion and exclusion criteria, and will receive 100mcL/kg (20 mg/kg) parenteral L-carnitine once daily until hospitalization or up to 14 days along with the standard care recommended by the Iranian Ministry of Health protocol.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: (placebo + standard care): 50 patients with COVID-19 will be included in the study based on the inclusion and exclusion criteria, and will receive the equivalent volume of L-carnitine as100mcL/kg from normal saline serum once daily until hospitalization or a maximum of 14 days along with the standard care recommended by the Iranian Ministry of Health protocol", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": 720, "treatment_name": "L-carnitine", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]